Use of VAP-1 inhibitors for treating fibrotic conditions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9795671
APP PUB NO 20130195883A1
SERIAL NO

13395029

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY OF BIRMINGHAMBIRMINGHAM B15 2TT
BIOTIE THERAPIES CORP20520 TURKU

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Österman, Thua Turku, FI 2 2
Adams, David Birmingham, GB 93 1005
Claridge, Lee Charles Kingswinford, GB 2 2
Pihlavisto, Marjo Kaarina, FI 14 27
Smith, David Naantali, FI 516 10998
Westerlund, Nina Turku, FI 2 2
Weston, Christopher Stourbridge, GB 4 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00